Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INS068 vs Insulin Degludec in Type 2 Diabetes
NCT04663282Phase 2Completed
- Sponsor
- Hengrui
- Start
- Feb 2021
- Primary completion
- May 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 3
01
Overview
A Phase 2 trial of insulin degludec in type 2 diabetes mellitus (T2DM), sponsored by Hengrui. Started Feb 2021; status: completed.
02
Drugs
insulin degludec
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT04663282.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04663282.